MICHAEL M BABICH

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology PITTSBURGH, PA NPI 1598764458

General Payments — all program years on this page

$116,439.16

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 204
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $13,574.06 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $26,399.3644
2019 $26,852.3047
2020 $12,897.4720
2021 $17,839.6121
2022 $12,652.2025
2023 $6,224.1629
2024 $13,574.0618

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078591327 Janssen Biotech, Inc. $26.51 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078592526 Janssen Biotech, Inc. $18.53 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078593500 Janssen Biotech, Inc. $17.69 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078593861 Janssen Biotech, Inc. $19.72 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078594718 Janssen Biotech, Inc. $26.10 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078595160 Janssen Biotech, Inc. $20.81 11/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078595987 Janssen Biotech, Inc. $17.99 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091991507 Ipsen Biopharmaceuticals, Inc $4,308.00 08/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1091991509 Ipsen Biopharmaceuticals, Inc $4,308.00 07/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1091991511 Ipsen Biopharmaceuticals, Inc $4,308.00 10/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1091991513 Ipsen Biopharmaceuticals, Inc $123.72 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091991515 Ipsen Biopharmaceuticals, Inc $135.52 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091991517 Ipsen Biopharmaceuticals, Inc $118.58 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103259211 ABBVIE INC. $21.02 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116587865 GlaxoSmithKline, LLC. $28.13 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133775439 Gilead Sciences, Inc. $20.25 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137477617 Takeda Pharmaceuticals U.S.A., Inc. $26.14 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137477620 Takeda Pharmaceuticals U.S.A., Inc. $29.35 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.